CN103142975B - Medicament for reducing blood fat - Google Patents
Medicament for reducing blood fat Download PDFInfo
- Publication number
- CN103142975B CN103142975B CN201310108437.2A CN201310108437A CN103142975B CN 103142975 B CN103142975 B CN 103142975B CN 201310108437 A CN201310108437 A CN 201310108437A CN 103142975 B CN103142975 B CN 103142975B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- semen
- folium
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for reducing blood fat. The medicament is prepared from the following materials in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of dried ginger, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of rhizoma coptidis, 5-15 parts of chrysanthemum, 10-30 parts of solidago canadensis, 1-15 parts of henbane, 10-20 parts of ephedra, 15-30 parts of pyrrosia leaf, 20-30 parts of tabasheer, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of gallnut, 10-30 parts of fructus ligustri lucidi, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of semen pharbitidis, 15-20 parts of japanese inula herb, 15-30 parts of sarcandra glabra, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of semen plantaginis, 15-25 parts of folium rhododendri daurici, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of semen oroxyli, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon fruit and 10-25 parts of chinese azalea flower. All the components of the medicament for reducing blood fat are natural materials, so that the medicament has good safety and clear curative effect and is suitable for large-scale clinical popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament of blood fat reducing.
Background technology
Hyperlipemia mainly refers to serum total cholesterol (TC) or triglyceride (TG) level is too high and (or) Serum High-Density Lipoprotein-Cholesterol (HDL-C) level is too low.Hyperlipemia is person in middle and old age's commonly encountered diseases and frequently-occurring disease, and along with the raising of people's living standard and the change of living habit, this sick sickness rate obviously increases, and the age of morbidity also shifts to an earlier date to some extent.The caused atherosclerosis of hyperlipemia is to cause the main cause of coronary heart disease, hypertension and cerebrovascular disease, and the whole world approximately has 1,200 ten thousand people to die from cardiovascular diseases and apoplexy every year.So the treatment of hyperlipemia is extremely important, this has caused showing great attention to of the whole mankind.The final purpose for the treatment of hyperlipemia is to suppress arteriosclerotic further developing, thereby prevents the death that caused by cardio-cerebrovascular diseases.
Summary of the invention
The medicament that the object of this invention is to provide a kind of blood fat reducing.
In order to realize object of the present invention, the invention provides a kind of medicament of blood fat reducing, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Concretio Silicea Bambusae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Galla Chinensis 10-25 part, Fructus Ligustri Lucidi 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Semen Plantaginis 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Semen Oroxyli 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
Preferably, the medicament of blood fat reducing of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Concretio Silicea Bambusaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Galla Chinensiss, 21 parts of Fructus Ligustri Lucidi, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Semen Plantaginiss, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Semen Oroxylis, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament of blood fat reducing of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Below by embodiment, further illustrate the present invention.It should be understood that embodiments of the invention are for the present invention rather than limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment decoction of the present invention
Take 7 grams of Radix Scrophulariaes, 13 grams of Rhizoma Zingiberiss, 22 grams of Fructus Corni, 15 grams of Radix Platycodoniss, 21 grams of Rhizoma Coptidis, 13 grams of Flos Chrysanthemis, 28 grams of Herba Solidaginiss, 11 grams of Semen Hyoscyamis, 17 grams, Herba Ephedrae, 24 grams of Folium Pyrrosiaes, 27 grams of Concretio Silicea Bambusaes, 18 grams of Radix Morindae Officinaliss, 17 grams of Herba Chelidoniis, 23 grams of Galla Chinensiss, 21 grams of Fructus Ligustri Lucidi, 16 grams of Fructus Phyllanthis, 16 grams of Folium Et Cacumen Murrayae, 17 grams of Semen Pharbitidiss, 19 grams of Herba Inulae, 15 grams of Herba Sarcandraes, 14 grams of Herba Clinopodii, 21 grams of Folium Sennae, 11 grams of Radix seu Herba Gei aleppici, 13 grams of Semen Plantaginiss, 23 grams of Folium Rhododendri Daurici, 24 grams of Herba Potentillae Discoloris, 14 grams of Calyx Seu Fructus Physaliss, 25 grams of Semen Oroxylis, 26 grams of Herba Eupatorii Lindleyanis, 24 grams of 16 grams of Semen Euryaless and Flos Rhododendri Mollis, add 2000 milliliters, water, in being housed, at 80 ℃, heats 4 hours by the flask of condensing tube, filter.Filtrate is concentrated into 600 milliliters, obtains decoction of the present invention.
Experimental example
This group of clinical data case 50 examples, all meet hyperlipemia diagnostic criteria (the dyslipidemia diagnostic criteria that < < China cardiovascular magazine > > editorial board dyslipidemia Preventing Countermeasures special topic group is formulated) [Chinese Journal of Cardiology editorial board. dyslipidemia Preventing Countermeasures special topic group. dyslipidemia control suggestion [J]. Chinese Journal of Cardiology, 1997,25 (3): 169.], male 25 examples wherein, female's 25 examples; 35～71 years old age, average 52 years old.
Use the decoction of preparation in embodiment 1 to treat, every day 3 times, each oral 150 milliliters.Treating 3 months is 1 course for the treatment of.
With reference to < < new Chinese medicine guideline of clinical investigations > > (Zheng Xiao cornel. new Chinese medicine guideline of clinical investigations (trying) [S]. Beijing. Chinese Medicine science and technology publishing house, 2002:85～89.) work out criterion of therapeutical effect.Respectively before and after treatment all on an empty stomach after 12h in venous blood samples in early morning, measure the indices such as TC, TG, LDL-C, HDL-C, conscience, renal function and blood, urine, stool routine.Effective: lipids detection reaches following any one person: TC decline >=20%, TG and declines >=40%.HDL-C rising >=0.26mmol/L, TC-LDL-C/HDL-C >=20%.Effective: lipids detection reaches following any one person: TC and declines >=10% but < 20%, TG declines >=20% but < 40%.HDL-C rising >=0.104mmol/L but < 0.26mmol/L, TC-LDL-C/HDL-C >=10% but < 20%.Invalid: lipids detection does not reach above standard person.
Through the treatment of a course for the treatment of, find that there is 45 patient treatment effects effective, 5 patient treatment effects are effective, and total effective rate rate is 100%, and during whole treatment, does not observe obvious untoward reaction.
Claims (2)
1. the medicament of a blood fat reducing, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Concretio Silicea Bambusae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Galla Chinensis 10-25 part, Fructus Ligustri Lucidi 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Semen Plantaginis 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Semen Oroxyli 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament of blood fat reducing according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Concretio Silicea Bambusaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Galla Chinensiss, 21 parts of Fructus Ligustri Lucidi, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Semen Plantaginiss, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Semen Oroxylis, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310108437.2A CN103142975B (en) | 2013-03-22 | 2013-03-22 | Medicament for reducing blood fat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310108437.2A CN103142975B (en) | 2013-03-22 | 2013-03-22 | Medicament for reducing blood fat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103142975A CN103142975A (en) | 2013-06-12 |
| CN103142975B true CN103142975B (en) | 2014-05-07 |
Family
ID=48541484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310108437.2A Expired - Fee Related CN103142975B (en) | 2013-03-22 | 2013-03-22 | Medicament for reducing blood fat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103142975B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104174004A (en) * | 2014-09-11 | 2014-12-03 | 彭海明 | Medicament for lowering blood fat |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101293081A (en) * | 2007-04-28 | 2008-10-29 | 陈小莺 | Medicament for treating hyperlipemia and preparation method thereof |
-
2013
- 2013-03-22 CN CN201310108437.2A patent/CN103142975B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101293081A (en) * | 2007-04-28 | 2008-10-29 | 陈小莺 | Medicament for treating hyperlipemia and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 六味地黄煎剂研究 Ⅰ.全方及拆方对小鼠耐缺氧与降血脂的作用;王秋娟等;《中国药科大学学报》;19900830;第21卷(第04期);241-242 * |
| 王秋娟等.六味地黄煎剂研究 Ⅰ.全方及拆方对小鼠耐缺氧与降血脂的作用.《中国药科大学学报》.1990,第21卷(第04期),241-242. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103142975A (en) | 2013-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101664482B (en) | Externally-applied medicine for treating beriberi and skin pruritus and preparation method thereof | |
| CN102205046B (en) | Medicament for reducing blood fat | |
| CN101099787A (en) | Traditional Chinese medicinal composition with remarkable wide-spectrum antiviral action | |
| CN103142975B (en) | Medicament for reducing blood fat | |
| Biplov et al. | Documentation and utilization pattern of ethno-medicinal plants in Darjeeling Himalayas, India | |
| CN103142982A (en) | Medicine for treating acute upper respiratory infection | |
| CN106543249A (en) | It is a kind of that the preparation method for preventing and treating hyperuricemia and the medicinal monomer of gout is extracted from Rhizoma Polygoni Cuspidati | |
| CN103142959A (en) | Medicament for treating urticaria | |
| CN102727753A (en) | Traditional Chinese medicine composition used for treating gout, and preparation method and application thereof | |
| CN103181961A (en) | Preparation method of flavonoid medicine for treating frostbite | |
| CN101537148A (en) | External application drug for curing eczema and preparation method thereof | |
| CN103191385B (en) | Medicament for treating infantile asthma | |
| CN104174004A (en) | Medicament for lowering blood fat | |
| CN103142974B (en) | Medicament for treating anxiety disorder | |
| CN103159597A (en) | Comprehensive exploration and utilization of active ingredients in branches and leaves of weeping willows | |
| CN101152202B (en) | Pharmaceutical composition for treating apparatus respiratorius disease and method for preparing the same | |
| CN103142954A (en) | Medicine for treating asthma | |
| CN1827138A (en) | Chinese medicine composition prescription for treating cardiovascular and cerebrovascular diseases and preparation technique thereof | |
| CN103948736B (en) | The compound Chinese medicinal preparation for the treatment of hepatocarcinoma and production method thereof | |
| CN103272192B (en) | Medicament for treating perianal abscess | |
| CN102357135A (en) | Traditional Chinese medicine oral liquid for preventing and treating chicken caecum coccidiosis and preparation method thereof | |
| CN107029060A (en) | Treat Yao medicinal composition of apoplexy and preparation method thereof | |
| CN106376928A (en) | Method for preparing compound dendrobium officinale health product assisting in reducing blood sugar | |
| CN103142977A (en) | Medicament for treating dysmenorrhea | |
| CN103110924A (en) | Medicine for treating hemorrhoids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG YONG Free format text: FORMER OWNER: SUN QIUJU Effective date: 20140401 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Yong Inventor before: Sun Qiuju |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272501 JINING, SHANDONG PROVINCE TO: 272100 JINING, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: SUN QIUJU TO: ZHANG YONG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140401 Address after: Department of Radiology, the first people's Hospital of health No. 6 road 272100 in Shandong province Jining City Applicant after: Zhang Yong Address before: 272501 Shandong province Dehui Wenshang County Road No. 2 Applicant before: Sun Qiuju |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140507 Termination date: 20150322 |
|
| EXPY | Termination of patent right or utility model |